Sangamo Therapeutics Inc (SGMOQ) Smart Money Holdings (13F, Q2 2026)

SGMOQ ranks #10944 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

SGMOQ is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

7 institutions disclose a position in SGMOQ, but none treat it as a major bet — even Jane Street Group, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Jane Street Group, LLC has trimmed its SGMOQ position for two straight quarters, cutting it by $1.2M while still holding $32.9K.

SGMOQ reported a net loss of $123.3M over the trailing twelve months.

• Not yet profitable — net loss of $123.3M over the trailing twelve months
• Revenue declined 45.8% year over year
• Net income declined year over year, from -$79.4M to -$123.3M
• Operating cash flow was negative, using $97.2M in cash
• Current ratio of 0.84x — below the conventional 1.5x liquidity buffer
• Total liabilities currently exceed total assets (negative shareholder equity)